ubenimex
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ubenimex, covering 2023-01-18 to 2023-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) [Phase 2]